התחברות ל-baba News

חשבון אחד לאתר, לאייפון ולאנדרואיד — המנוי נשאר איתכם.

או קוד במייל

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the monthly limit

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. תנאי המנוי.

המנוי פותח גם את האפליקציה.

חיפוש סיפורים

הקלידו לפחות שני תווים. התוצאות מגיעות מכל המערכות ש-baba קורא.

↑↓ למעבר · ↵ לפתיחה · esc לסגירה

התחברות ל-baba News

Sign in to keep asking. News Plus removes the daily limit.

או קוד במייל

לראות את התמונה המלאה

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the monthly limit

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. תנאי המנוי.

המנוי פותח גם את האפליקציה.

בריאות04:22 · Jun 15

AI-Designed Vaccine Passes Human Trial, Raising Hope Against Future Pandemics

מאת ערוץ 7
תורגם ותומצת מתוך Arutz Sheva על ידי baba
The story · English

For the first time, a vaccine developed entirely by artificial intelligence has successfully passed a human trial, according to the report. The breakthrough was highlighted by i24news, which said researchers believe the technology could help prevent the next pandemic.

The article says the vaccine was created fully by AI from start to finish, and that scientists think it may offer protection against thousands of viruses. If that promise holds up, they say it could become a tool for stopping future outbreaks before they spread widely.

Researchers cited in the report believe the development could save millions of lives. The piece frames the vaccine as a major scientific advance that is drawing global attention because of its potential to change how medicine responds to viral threats.

No further details were provided about the trial’s location, the company or institution behind the vaccine, or the next regulatory steps, but the report presents the successful human test as an important first milestone.

Read the original at Arutz Sheva

Ask About This Article

Duki reads it, and every newsroom on the same story, then answers with sources.

פתיחת המסוף החי